Susquehanna International Group’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.8M | Sell |
484,874
-138,789
| -22% | -$6.52M | ﹤0.01% | 397 |
|
|
2025
Q1 | $27.5M | Buy |
623,663
+486,638
| +355% | +$21.5M | ﹤0.01% | 270 |
|
|
2024
Q4 | $4.95M | Buy |
137,025
+22,210
| +19% | +$802K | ﹤0.01% | 1100 |
|
|
2024
Q3 | $3.68M | Sell |
114,815
-27,902
| -20% | -$894K | ﹤0.01% | 1324 |
|
|
2024
Q2 | $5.38M | Sell |
142,717
-95,828
| -40% | -$3.61M | ﹤0.01% | 974 |
|
|
2024
Q1 | $11.7M | Buy |
238,545
+107,886
| +83% | +$5.31M | ﹤0.01% | 563 |
|
|
2023
Q4 | $4.77M | Buy |
130,659
+90,429
| +225% | +$3.3M | ﹤0.01% | 1186 |
|
|
2023
Q3 | $930K | Sell |
40,230
-3,395
| -8% | -$78.5K | ﹤0.01% | 2648 |
|
|
2023
Q2 | $1.14M | Sell |
43,625
-83,924
| -66% | -$2.2M | ﹤0.01% | 2534 |
|
|
2023
Q1 | $3.28M | Buy |
127,549
+103,499
| +430% | +$2.66M | ﹤0.01% | 1423 |
|
|
2022
Q4 | $626K | Sell |
24,050
-85,408
| -78% | -$2.22M | ﹤0.01% | 2906 |
|
|
2022
Q3 | $3.12M | Buy |
109,458
+33,890
| +45% | +$967K | ﹤0.01% | 1226 |
|
|
2022
Q2 | $1.86M | Buy |
75,568
+52,775
| +232% | +$1.3M | ﹤0.01% | 1741 |
|
|
2022
Q1 | $1.29M | Sell |
22,793
-16,775
| -42% | -$946K | ﹤0.01% | 2519 |
|
|
2021
Q4 | $2.45M | Buy |
39,568
+13,744
| +53% | +$852K | ﹤0.01% | 1753 |
|
|
2021
Q3 | $1.64M | Buy |
25,824
+14,405
| +126% | +$914K | ﹤0.01% | 2161 |
|
|
2021
Q2 | $941K | Sell |
11,419
-4,430
| -28% | -$365K | ﹤0.01% | 3056 |
|
|
2021
Q1 | $1.17M | Buy |
15,849
+2,878
| +22% | +$212K | ﹤0.01% | 2785 |
|
|
2020
Q4 | $941K | Buy |
+12,971
| New | +$941K | ﹤0.01% | 2654 |
|
|
2019
Q4 | – | Sell |
-14,392
| Closed | -$312K | – | 4769 |
|
|
2019
Q3 | $312K | Buy |
+14,392
| New | +$312K | ﹤0.01% | 3366 |
|